57894-060 : Stelara 45 mg/.5ml Subcutaneous Injection, Solution
NDC: | 57894-060 |
Labeler: | Janssen Biotech, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Stelara |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA125261 |
Rev. Date: |
NDC Package Codes:
- 57894-060-02: 1 VIAL, SINGLE‑USE IN 1 CARTON (57894‑060‑02) > .5 ML IN 1 VIAL, SINGLE‑USE
- 57894-060-03: 1 SYRINGE IN 1 CARTON (57894‑060‑03) > .5 ML IN 1 SYRINGE
- 57894-060-04: 1 SYRINGE IN 1 CARTON (57894‑060‑04) > .5 ML IN 1 SYRINGE
Active Ingredients:
- Ustekinumab
Dosage Strength:
- 45 mg/.5mL
Pharmaceutical Classes:
- Interleukin-12 Antagonists [MoA]
- Interleukin-23 Antagonist [EPC]
- Interleukin-23 Antagonists [MoA]
- Interleukin-12 Antagonist [EPC]
Related Products:
Based on records with the same trade name.- 57894-054 Stelara 130 mg/26ml Intravenous Solution by Janssen Biotech, Inc.
- 57894-061 Stelara 90 mg/ml Subcutaneous Injection, Solution by Janssen Biotech, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 57894-054Next: 57894-061 >
Related Discussions:
Stelara Study
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past... 3 replies
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past... 3 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.